Apriem Advisors

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1425165 IRVINE, CA

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$270,616

-$6,031,035 QoQ

Shares Held

434

-94.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#967

of 1,322 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

Apriem Advisors holds $270,616 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	434	$270,616

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$270,616	434	-94.7%	Shares	Sole	2026-08-14
2026-03-31	$6,301,651	8,156	-5.0%	Shares	Sole	2026-05-15
2025-12-31	$6,625,732	8,584	-0.7%	Shares	Sole	2026-02-13
2025-09-30	$4,862,510	8,648	-5.1%	Shares	Sole	2025-11-10
2025-06-30	$4,786,425	9,117	-26.7%	Shares	Sole	2025-08-14
2025-03-31	$7,887,284	12,436	-14.2%	Shares	Sole	2025-05-15
2024-12-31	$10,324,511	14,494	-6.7%	Shares	Sole	2025-02-05
2024-09-30	$16,322,603	15,527	-4.9%	Shares	Sole	2024-11-14
2024-06-30	$17,166,472	16,333	-21.2%	Shares	Sole	2024-08-14
2024-03-31	$19,945,680	20,723	-13.0%	Shares	Sole	2024-05-15
2023-12-31	$20,919,111	23,818	-4.4%	Shares	Sole	2024-02-14
2023-09-30	$20,505,694	24,917	-2.7%	Shares	Sole	2023-11-13
2023-06-30	$18,396,061	25,602	-1.9%	Shares	Sole	2023-08-08
2023-03-31	$21,451,338	26,107	-16.8%	Shares	Sole	2023-05-12
2022-12-31	$22,634,584	31,372	-2.7%	Shares	Sole	2023-02-13
2022-09-30	$22,214,679	32,248	+0.1%	Shares	Sole	2022-11-14
2022-06-30	$19,046,208	32,220	+0.3%	Shares	Sole	2022-08-08
2022-03-31	$22,445,821	32,138	+1.2%	Shares	Sole	2022-05-10
2021-12-31	$20,052,023	31,752	—	Shares	Sole	2022-02-09
No filing history on record for this holder in this stock.